Atlas Trials

NCRT Combined With Sequential Perioperative PD-1 Inhibitor for LAESCC

Clinical trial NCT06762158 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06762158
Sponsor
RenJi Hospital
Status
ACTIVE_NOT_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Esophageal Squamous Cell Carcinoma (ESCC)
Start date
2024-10-30
Primary completion
2027-12-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.